Conquering Diseases

Study Of An Investigational Drug For Relapsing Forms Of Multiple Sclerosis:Click-Ms

Description

Seeking men and women whose multiple sclerosis has not responded well to previous treatment and whose doctor has decided to start treatment with cladribine tablets and stop treatment with an injectable drug.

Overview

In this study researchers will collect data about the treatment that volunteers with relapsing multiple sclerosis and their doctors decide upon as part of their normal care. At times, volunteers will be asked to complete questionnaires about their health.

What we're hoping for

We hope to evaluate the effectiveness of the investigational drug on relapsing multiple sclerosis when used as part of routine care and to better understand treatment for relapsing multiple sclerosis

Additional Information

ClinicalTrials.gov Identifier: NCT03933215

 Principal Investigator

Andrew J. Bouley, MD

University of Massachusetts Medical School

 Study Contact

Melissa  Adams

508-856-4676

melissa.adams@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989